“The new US precision medicine initiative, including the All of Us program, has been made possible by improvement and price reduction in genome sequencing, as well as advances in multiple sectors of biotechnology. The initiative includes two components: a focus on…
The results of the Steroids in Eosinophil Negative Asthma (SIENA) trial emphasize the importance of a personalized approach to the treatment of asthma. For a given condition, there are likely many different subtypes of patients who may respond differently to different…
It has come to our attention that pharmacogenetic tests for drugs used for the treatment of ADHD and analgesics have been removed by other pharmacogenetic platforms. We believe that these actions are appropriate given the low levels of evidence for many…
Clinical outcome studies show cost savings and improved patient outcomes with pharmacogenetics in cardiovascular and mental health as well as in other areas including infectious disease, long term care, and adverse drug reactions Cardiovascular Antiplatelet post-MI Notarangelo et al 2018. PMID…
Finding the correct treatment may sometimes take years and adverse drug reactions may be inevitable, especially for people suffering from chronic conditions that require long term medication treatment plans. When dealing with these health issues, it is often hard for employees…
We are delighted to be included in the 2019 selections for the Digital Health Emerging Rockets. This list profiles technology companies that will lead market breakthroughs by providing tools and services to facilitate better health. GenXys is a precision prescribing software…
Great article in the Financial Post on big data and innovation, particularly in health technology. “Move over oil, Big Data is the new fuel to run the world Innovation Nation: With only a sliver of all data collected being analyzed, this…
These fascinating peer-reviewed papers from 2018 keep building the foundation for the implementation of precision prescribing in the clinic. From mental health to cardiovascular disease and diabetes, this compilation shows that precision medicine is much more than genomics. The degree of…
GenXys, a precision prescribing software company tackling a $130 billion global problem, is pleased to announce that it has closed its oversubscribed seed round at $1.77 million, with key investors TYDO and TELUS Ventures. Following early commercial success in Canada, this…
The SHRM (Society for Human Resource Management) on precision health & genetic testing for employers A recent SHRM article referenced the Precision Prescribing Software Review Infographic emphasizing that ‘Genetic testing can help with precision prescribing of medications, which takes into account…
Recent Comments